Merck says it has the first antiviral pill effective against Covid

with No Comments
Health officials said the drug could provide an effective way to treat Covid-19, but stressed that vaccines remained the best tool to prevent infections.

 

(Rebecca Robbins/ New York Times) — The drug maker Merck said on Friday that its pill to treat Covid-19 was shown in a key clinical trial to halve the risk of hospitalization or death when given to high-risk people early in their infections.

The strong results suggest that a new wave of effective and easy-to-use treatments for Covid will gradually become available in the United States, though supply is likely to be limited at first. Merck said it would seek emergency authorization from the Food and Drug Administration for its drug, known as molnupiravir, as soon as possible. The pills could be available by late this year.

Merck’s drug would be the first pill to treat Covid-19; it is likely to be followed by a number of other antiviral pills that other companies are racing to bring to market. They have the potential to reach more people than the antibody treatments that are being widely used in the United States for high-risk patients. (…)

read full story